Adolescent use of combined hormonal contraception and peak bone mineral density accrual: A meta‐analysis of international prospective controlled studies
Open Access
- 7 January 2019
- journal article
- review article
- Published by Wiley in Clinical Endocrinology
- Vol. 90 (4) , 517-524
Abstract
Summary: Objective: Many women use combined hormonal contraceptives (CHC) during adolescence during which they are accruing peak areal bone mineral density (BMD) that relates to lifetime fracture risk. To build BMD requires formation with which CHC‐related exogenous oestrogen may interfere. We compared peak BMD accrual in adolescents using and not using CHC.Design/Participants: We performed literature searches for prospective published peer‐reviewed articles providing 12‐ to 24‐month BMD change in adolescent (12‐ to 19‐year‐old) women using CHC vs CHC‐unexposed control women.Methods: Meta‐analyses used random‐effects models to assess BMD change rate at lumbar spine (LS) and other sites in adolescent CHC users vs CHC nonusers.Results: Literature searches yielded 84 publications of which nine were eligible. Adolescent‐only data were sought from cohorts with wider age inclusions. The 12‐month LS meta‐analysis with eight paired comparisons in 1535 adolescents showed a weighted mean BMD difference of −0.02 (95% confidence interval [CI]: −0.05 to 0.00) g/cm2 in CHC‐exposed adolescents (P = 0.04). The 24‐month LS meta‐analysis with five paired comparisons in 885 adolescents showed a highly significant weighted mean BMD difference of −0.02 (95% CI: −0.03 to −0.01) g/cm2 in CHC‐exposed adolescents (P = 0.0006). Heterogeneities by I2 were 96% and 85%, respectively. Insufficient data for other bone sites precluded quantitative analysis.Conclusion: Given that adolescent exposure to CHC appears to be increasing, this evidence for potential impairment of peak spinal BMD accrual is of concern and suggests a potential public health problem. Randomized controlled trial data are needed to determine CHC effects on adolescent bone health.Keywords
This publication has 29 references indexed in Scilit:
- Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent womenContraception, 2012
- Oral Contraceptive Use and Bone Density Change in Adolescent and Young Adult Women: A Prospective Study of Age, Hormone Dose, and DiscontinuationThe Journal of Clinical Endocrinology & Metabolism, 2011
- Peak bone mass from longitudinal data: Implications for the prevalence, pathophysiology, and diagnosis of osteoporosisJournal of Bone and Mineral Research, 2010
- Peak bone mineral density, lean body mass and fracturesBone, 2010
- Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective studyFertility and Sterility, 2008
- Effects of Depot Medroxyprogesterone Acetate and 20-Microgram Oral Contraceptives on Bone Mineral DensityObstetrics & Gynecology, 2008
- Prior oral contraception and postmenopausal fracture: a Women’s Health Initiative observational cohort studyFertility and Sterility, 2005
- A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptivesThe Journal of Pediatrics, 1996
- Weight-bearing activity during youth is a more important factor for peak bone mass than calcium intakeJournal of Bone and Mineral Research, 1994
- Oral contraceptive pill use and fractures in women: A prospective studyBone, 1993